These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19138979)

  • 1. Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.
    Nemenoff R; Meyer AM; Hudish TM; Mozer AB; Snee A; Narumiya S; Stearman RS; Winn RA; Weiser-Evans M; Geraci MW; Keith RL
    Cancer Prev Res (Phila); 2008 Oct; 1(5):349-56. PubMed ID: 19138979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention.
    New ML; White CM; McGonigle P; McArthur DG; Dwyer-Nield LD; Merrick DT; Keith RL; Tennis MA
    Cancer Prev Res (Phila); 2018 Oct; 11(10):643-654. PubMed ID: 30045935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TARGETING THE PROSTACYCLIN/PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AXIS IN LUNG CANCER CHEMOPREVENTION.
    Geraci MW
    Trans Am Clin Climatol Assoc; 2018; 129():48-55. PubMed ID: 30166698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.
    Falcetti E; Hall SM; Phillips PG; Patel J; Morrell NW; Haworth SG; Clapp LH
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1161-70. PubMed ID: 20622039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model.
    Dwyer-Nield L; Hickey GA; Friedman M; Choo K; McArthur DG; Tennis MA; New ML; Geraci M; Keith RL
    Cancer Prev Res (Phila); 2017 Nov; 10(11):671-679. PubMed ID: 28851689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
    Ahn JH; Lee KT; Choi YS; Choi JH
    Prostaglandins Other Lipid Mediat; 2018 Jan; 134():47-56. PubMed ID: 29292033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle.
    Battersby S; Critchley HO; de Brum-Fernandes AJ; Jabbour HN
    Reproduction; 2004 Jan; 127(1):79-86. PubMed ID: 15056772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.
    Keith RL; Miller YE; Hudish TM; Girod CE; Sotto-Santiago S; Franklin WA; Nemenoff RA; March TH; Nana-Sinkam SP; Geraci MW
    Cancer Res; 2004 Aug; 64(16):5897-904. PubMed ID: 15313935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.
    Keith RL; Karoor V; Mozer AB; Hudish TM; Le M; Miller YE
    Lung Cancer; 2010 Oct; 70(1):37-42. PubMed ID: 20116128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.
    Tennis MA; Van Scoyk M; Heasley LE; Vandervest K; Weiser-Evans M; Freeman S; Keith RL; Simpson P; Nemenoff RA; Winn RA
    Neoplasia; 2010 Mar; 12(3):244-53. PubMed ID: 20234818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
    Li Y; Connolly M; Nagaraj C; Tang B; Bálint Z; Popper H; Smolle-Juettner FM; Lindenmann J; Kwapiszewska G; Aaronson PI; Wohlkoenig C; Leithner K; Olschewski H; Olschewski A
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):372-9. PubMed ID: 22021335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.
    Falcetti E; Flavell DM; Staels B; Tinker A; Haworth SG; Clapp LH
    Biochem Biophys Res Commun; 2007 Sep; 360(4):821-7. PubMed ID: 17624303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release.
    Wilson SM; Sheddan NA; Newton R; Giembycz MA
    Mol Pharmacol; 2011 Mar; 79(3):586-95. PubMed ID: 21173040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-520a-5p regulates Frizzled 9 expression and mediates effects of cigarette smoke and iloprost chemoprevention.
    Smith AJ; Do P; Sompel K; Elango A; Tennis MA
    Sci Rep; 2022 Feb; 12(1):2388. PubMed ID: 35149732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.
    Ali FY; Egan K; FitzGerald GA; Desvergne B; Wahli W; Bishop-Bailey D; Warner TD; Mitchell JA
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):242-6. PubMed ID: 16239641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells.
    Wilson SM; Shen P; Rider CF; Traves SL; Proud D; Newton R; Giembycz MA
    J Immunol; 2009 Nov; 183(10):6788-99. PubMed ID: 19880449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin receptor signaling and early embryo development in the mouse.
    Huang JC; Wun WS; Goldsby JS; Egan K; FitzGerald GA; Wu KK
    Hum Reprod; 2007 Nov; 22(11):2851-6. PubMed ID: 17905746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
    Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
    Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle.
    Arbab F; Goldsby J; Matijevic-Aleksic N; Huang G; Ruan KH; Huang JC
    Hum Reprod; 2002 Dec; 17(12):3053-9. PubMed ID: 12456602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCP crystals increase prostacyclin production and upregulate the prostacyclin receptor in OA synovial fibroblasts: potential effects on mPGES1 and MMP-13.
    Molloy ES; Morgan MP; McDonnell B; O'Byrne J; McCarthy GM
    Osteoarthritis Cartilage; 2007 Apr; 15(4):414-20. PubMed ID: 17123841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.